[Diagnostic value of low versus high titers of MOG-IgG and their clinical implications in myelin oligodendrocyte glycoprotein antibody-associated disease: a retrospective singlecenter study]. [PDF]
Nan Fang Yi Ke Da Xue Xue Bao, 2023 Li Z +5 more
europepmc +1 more source
Clinical features of 28 cases of anti-leucine-rich glioma-inactivated protein 1 encephalitis and anti-contactin-associated protein-like 2 encephalitis. [PDF]
Zhong Nan Da Xue Xue Bao Yi Xue Ban, 2023 Feng J +5 more
europepmc +1 more source
Preparation and Preliminary application of Dextran Quantitative Detection Kit [PDF]
, 2016 右旋糖酐（Dextran），又名葡聚糖，由Leuconostocmesenteroides等微生物产生的酶聚合葡萄糖而成或葡萄糖通过化学聚合而成。右旋糖酐广泛应用于医药、食品、化工等领域。在医学领域的应用主要包括：作为血浆体积扩张剂，作为抗凝剂，以及作为渗透压调节剂用于相关的疾病治疗。一般机体组织细胞并不能直接利用右旋糖酐，主要从尿液排出，右旋糖酐使用过量会引起急性肾衰竭、充血性心衰竭、肺水肿及血小板减少等毒副作用。因此，监测血液、尿液的右旋糖酐含量是指导右旋糖酐用量的重要指标 ...
王生育
core
Zhongshan Daxue xuebao. Yixue kexue ban, 2000 【目的】获得可递呈抗低分化和未分化癌细胞单克隆抗体(BAC5 单抗)抗原表位的M13噬菌体克隆系。【方法】以 BAC5 单抗为靶抗体, 对由M13噬菌体构建的随机12 肽文库进行生物淘洗。用抗体竞争方法从阳性克隆中选出与BAC5 单抗结 合率较高的克隆系。通过ELISA 方法检测BAC5 单抗对上述克隆的选择性识别。【结果】经过3 轮淘洗, 获得的阳性克隆率为 77 %(35/ 45)。来自C2、C17 和C29 号克隆的噬菌体对外加BAC5 单抗的结合率分别为71.6 %、49.4 %和64.0%
肖锡宾 +5 more
doaj
[Clinical advances in bispecific antibodies for hematological malignancies]. [PDF]
Zhonghua Xue Ye Xue Za Zhi, 2023 Cai YM, Wu DP, Xu Y.
europepmc +1 more source
[Correlation of anti-phosphatidylserine/prothrombin antibodies with unexplained recurrent miscarriages]. [PDF]
Beijing Da Xue Xue Bao Yi Xue Ban, 2023 Yao ZQ +7 more
europepmc +1 more source
Zhongguo shiyan zhenduanxue, 2007 目的制备针对超嗜热古菌组蛋白HPhA的单克隆抗体并进行鉴定。方法以重组纯化蛋白HPhA为抗原,用聚乙二醇（PEG）法制备杂交瘤细胞,ELISA检测杂交瘤细胞分泌抗体的效价和类型,Western blotting分析抗体的特异性。结果获得3株稳定分泌抗HPhA蛋白的单克隆抗体（MAb）,3株单克隆抗体1A12、3C11、3B4分别属于IgG1、IgM和IgG2b亚类。ELISA和Western blotting结果显示,单克隆抗体3B4能特异性结合HPhA及PEA-HPhA重组蛋白 ...
张玲, 郑艳军, 朱平, 张国利
doaj
[Anti-HMGCR immune-mediated necrotizing myopathy: A case report]. [PDF]
Beijing Da Xue Xue Bao Yi Xue Ban, 2023 Zhang YJ +6 more
europepmc +1 more source
Immunity/inflammation-mediated pathophysiological mechanisms of atherosclerosis and clinical applications of antibody technology [PDF]
, 2013 Matsuura, Eiji
core +1 more source
[Clinical Progress and Prospects of Antibody-drug Conjugates in Advanced NSCLC]. [PDF]
Zhongguo Fei Ai Za ZhiZhong Y, Wang J, Wu L.
europepmc +1 more source